Your browser is no longer supported. Please, upgrade your browser.
ACER Acer Therapeutics Inc. daily Stock Chart
ACER [NASD]
Acer Therapeutics Inc.
Index- P/E- EPS (ttm)-2.71 Insider Own0.30% Shs Outstand10.09M Perf Week-9.12%
Market Cap31.18M Forward P/E- EPS next Y-1.78 Insider Trans- Shs Float7.47M Perf Month-81.61%
Income-25.30M PEG- EPS next Q-0.79 Inst Own61.00% Short Float8.08% Perf Quarter-84.38%
Sales- P/S- EPS this Y-31.40% Inst Trans0.03% Short Ratio1.99 Perf Half Y-87.14%
Book/sh3.75 P/B0.82 EPS next Y37.80% ROA-61.70% Target Price8.33 Perf Year-84.37%
Cash/sh3.15 P/C0.98 EPS next 5Y- ROE-67.40% 52W Range2.73 - 34.10 Perf YTD-84.64%
Dividend- P/FCF- EPS past 5Y52.60% ROI- 52W High-90.94% Beta1.51
Dividend %- Quick Ratio10.90 Sales past 5Y- Gross Margin- 52W Low13.19% ATR0.90
Employees23 Current Ratio10.90 Sales Q/Q- Oper. Margin- RSI (14)21.55 Volatility10.00% 11.05%
OptionableNo Debt/Eq0.00 EPS Q/Q-48.70% Profit Margin- Rel Volume0.34 Prev Close3.06
ShortableYes LT Debt/Eq0.00 EarningsMay 13 Payout- Avg Volume302.80K Price3.09
Recom2.30 SMA20-46.21% SMA50-76.81% SMA200-85.06% Volume104,222 Change0.98%
Jun-26-19Reiterated H.C. Wainwright Buy $55 → $10
Jun-25-19Downgrade William Blair Outperform → Mkt Perform
Jun-25-19Downgrade Raymond James Outperform → Mkt Perform
May-23-19Initiated Wedbush Outperform
Feb-15-19Resumed Raymond James Outperform $40
Dec-20-18Initiated Needham Buy $48
Feb-26-18Initiated ROTH Capital Buy
Dec-20-17Initiated H.C. Wainwright Buy $50
Jul-19-19 07:15PM  SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuit Filed Against Acer Therapeutics, Inc. ACCESSWIRE
04:00PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acer Therapeutics Inc. To Contact The Firm ACCESSWIRE
03:00PM  Class Action Update - FedEx Corporation (FDX),  Acer Therapeutics Inc. (ACER)  & Diebold Nixdorf,  Incorporated (DBD) - Bronstein, Gewirtz & Grossman, LLC GlobeNewswire
01:00PM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:40AM  Class Action - FedEx Corporation (FDX), Acer Therapeutics Inc. (ACER) & Diebold Nixdorf, Incorporated (DBD) - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Jul-18-19 08:55PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acer Therapeutics Inc. GlobeNewswire +5.88%
05:55PM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
02:37PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline ACER GlobeNewswire
12:34PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acer Therapeutics Inc. To Contact The Firm GlobeNewswire
Jul-17-19 07:18PM  KESSLER TOPAZ MELTZER & CHECK, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Against ACER THERAPEUTICS, INC. ACER GlobeNewswire
02:15PM  SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:39AM  Class Action Update - FedEx Corporation (FDX), Acer Therapeutics Inc. (ACER) & Diebold Nixdorf, Incorporated (DBD) - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Jul-16-19 10:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ACER PR Newswire -9.39%
09:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Freds, Acer Therapeutics, and Diebold Nixdorf and Intelligent Systems and Encourages Investors to Contact the Firm GlobeNewswire
07:12PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acer Therapeutics Inc. GlobeNewswire
05:03PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
12:40PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acer Therapeutics Inc. To Contact The Firm ACCESSWIRE
12:15PM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Jul-15-19 07:58PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acer Therapeutics Inc. Business Wire
05:53PM  Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Acer Therapeutics, Inc. Business Wire
01:35PM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:40AM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acer Therapeutics Inc. To Contact The Firm ACCESSWIRE
10:39AM  Class Action Reminder - FedEx Corporation (FDX), Acer Therapeutics Inc. (ACER) & Diebold Nixdorf, Incorporated (DBD) - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Jul-13-19 08:00AM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Jul-12-19 06:59PM  Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Acer Therapeutics, Inc. - ACER PR Newswire
06:46PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acer Therapeutics Inc. Business Wire
03:00PM  SHAREHOLDER ALERT - Acer Therapeutics Inc. (ACER) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: August 30, 2019 GlobeNewswire
02:45PM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
01:15PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acer Therapeutics Inc. To Contact The Firm ACCESSWIRE
11:12AM  Zhang Investor Law Announces Securities Class Action Lawsuit Against Acer Therapeutics Inc. ACER GlobeNewswire
10:50AM  SHAREHOLDER ALERT - Acer Therapeutics Inc. (ACER) - Bronstein, Gewirtz & Grossman, LLC Notifies of Class Action and Lead Deadline: August 30, 2019 ACCESSWIRE
Jul-11-19 07:48PM  Kessler Topaz Meltzer & Check, LLP Announces A Securities Fraud Class Action Filed Against Acer Therapeutics, Inc. GlobeNewswire
03:25PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ACER ACCESSWIRE
Jul-10-19 03:45PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:41AM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against  Acer Therapeutics Inc. ACER GlobeNewswire
10:48AM  SHAREHOLDER ALERT - Acer Therapeutics Inc. (ACER) - Bronstein, Gewirtz & Grossman, LLC Notifies of Class Action and Lead Plaintiff Deadline: August 30, 2019 ACCESSWIRE
Jul-09-19 11:00AM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Jul-08-19 08:00PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Acer Therapeutics Inc. Investors Business Wire
06:53PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline ACER GlobeNewswire
05:10PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Acer Therapeutics Inc. Investors (ACER) Business Wire
01:35PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
10:49AM  SHAREHOLDER ALERT - Acer Therapeutics Inc. (ACER) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Plaintiff Deadline: August 30, 2019 ACCESSWIRE
Jul-05-19 05:45PM  Robbins Arroyo LLP: Acer Therapeutics Inc. (ACER) Misled Shareholders According to a Recently Filed Lawsuit Business Wire -7.59%
03:00PM  INVESTOR ALERT - Acer Therapeutics Inc. (ACER) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: August 30, 2019 GlobeNewswire
12:45PM  Newton drugmaker Acer cuts more than two dozen staff after FDA rejection American City Business Journals
12:35PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
08:30AM  Acer Therapeutics Announces Restructuring and Update on Pipeline Programs GlobeNewswire
08:16AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ACER ACCESSWIRE
Jul-04-19 03:26PM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Jul-03-19 08:00PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Acer Therapeutics Inc. Investors (ACER) Business Wire
07:04PM  INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for the Southern District of New York against Acer Therapeutics Inc. GlobeNewswire
05:54PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Acer Therapeutics Inc. To Contact The Firm PR Newswire
05:07PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Acer Therapeutics Inc. Investors (ACER) Business Wire
02:03PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
01:15PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
12:17PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Acer Therapeutics Inc. ACER Business Wire
Jul-02-19 07:30PM  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Acer Therapeutics, Inc. (ACER) GlobeNewswire
07:10PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
01:50PM  INVESTOR ALERT - Acer Therapeutics Inc. (ACER) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: August 30, 2019 ACCESSWIRE
10:43AM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Jul-01-19 09:30PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Acer Therapeutics (NASDAQ: ACER) and Encourages Acer Investors to Contact the Firm GlobeNewswire
03:35PM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acer Therapeutics Inc. (ACER) ACCESSWIRE
03:22PM  Pomerantz Law Firm Announces the Filing of a Class Action against Acer Therapeutics, Inc. and Certain Officers ACER GlobeNewswire
11:04AM  INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
07:14AM  Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Benzinga
Jun-30-19 03:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acer Therapeutics Inc. - ACER ACCESSWIRE
Jun-28-19 03:21PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acer Therapeutics Inc. - ACER ACCESSWIRE +13.04%
Jun-27-19 11:04AM  Bragar Eagel & Squire, P.C. is Investigating Acer Therapeutics, Diebold Nixdorf, Sunlands Technology Group, and PetIQ and Encourages Investors to Contact the Firm GlobeNewswire -10.39%
Jun-26-19 05:12PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire -6.55%
12:06PM  BARJO LAW INVESTOR ALERT: Barbuto & Johansson, P.A. Investigates Acer Therapeutics, Inc. After 80 Percent Plunge GlobeNewswire
08:32AM  Acer Shares Down on FDA's CRL for Genetic Disorder Treatment Zacks
07:19AM  The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart Benzinga
Jun-25-19 04:25PM  Acer Plummets After FDA Declines to OK Rare Genetic Disorder Treatment TheStreet.com -78.63%
03:20PM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acer Therapeutics Inc. (ACER) ACCESSWIRE
01:35PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acer Therapeutics Inc. - ACER GlobeNewswire
11:39AM  Acer Therapeutics stock plummets 80 percent on FDA rejection American City Business Journals
09:04AM  Acer Therapeutics stock loses over 80% of its value after receiving CRL from FDA for Edsivo MarketWatch
08:59AM  FDA declines to approve Acer Therapeutics' treatment for rare genetic disorder Reuters
08:49AM  UPDATE 2-FDA declines to approve Acer Therapeutics' rare genetic disorder treatment Reuters
08:36AM  FDA declines to approve Acer Therapeutics' treatment for rare genetic disorder Reuters
08:30AM  Acer Therapeutics Receives Complete Response Letter from U.S. FDA for use of EDSIVO (celiprolol) in vEDS Patients GlobeNewswire
Jun-10-19 03:23PM  Wedbush Remains Bullish On Acer Therapeutics, Says Edsivo Review Appears On Track Benzinga
May-31-19 08:30AM  Acer Therapeutics Announces Poster Presentation at Society for Vascular Medicine Annual Meeting GlobeNewswire
May-23-19 09:06AM  Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Healthcare and BioTech Space - ACER, ACOR, ALNX, BIIB, DOVA and SAGE PR Newswire
08:30AM  Acer Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire
May-14-19 04:01PM  Acer Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
May-07-19 08:30AM  Acer Therapeutics to Present at UBS Global Healthcare Conference GlobeNewswire
Apr-16-19 08:30AM  Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data GlobeNewswire
Apr-05-19 12:36PM  Introducing Acer Therapeutics (NASDAQ:ACER), A Stock That Climbed 27% In The Last Year Simply Wall St.
Mar-13-19 08:30AM  Acer Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire
Mar-07-19 04:01PM  Acer Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update GlobeNewswire
Jan-02-19 08:30AM  Acer Therapeutics Announces In-license of Osanetant from Sanofi GlobeNewswire +6.61%
Dec-26-18 04:09PM  Is This Biotech Stock Turning A Corner? Acer Pops On FDA Acceptance Investor's Business Daily +11.30%
08:30AM  Acer Therapeutics Announces FDA Acceptance of NDA and Priority Review for EDSIVO for the Treatment of vEDS GlobeNewswire
Dec-20-18 06:26AM  Opexa Therapeutics Enters Oversold Territory Zacks
Dec-17-18 08:30AM  Acer Therapeutics Appoints Salma Jutt as Chief Commercial Officer GlobeNewswire
Nov-09-18 04:01PM  Acer Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Nov-08-18 08:30AM  Acer Therapeutics to Present at the Evercore ISI HealthConX Conference GlobeNewswire
Oct-29-18 08:30AM  Acer Therapeutics Submits NDA for EDSIVO for the Treatment of vEDS GlobeNewswire
Oct-09-18 01:46PM  Do Institutions Own Shares In Acer Therapeutics Inc (NASDAQ:ACER)? Simply Wall St.
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes three clinical-stage candidates: EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; and ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders, maple syrup urine disease, and osanetant for the treatment of various neuroendocrine disorders. The company was founded in 2013 and is headquartered in Newton, Massachusetts.